Clinical Efficacy of Trabeculecto my Combined with Aminiotic Membrane Transplantation.
- Author:
Suk Han KIM
1
;
Dae Wook KIM
;
Woo Chan PARK
;
Sae Heun RHO
Author Information
1. .
- Publication Type:Original Article
- Keywords:
Trabeculectomy;
Amniotic membrane transplantation;
Intraocular pressure
- MeSH:
Amnion;
Anterior Chamber;
Blister;
Filtering Surgery;
Follow-Up Studies;
Glaucoma;
Glaucoma, Neovascular;
Glaucoma, Open-Angle;
Humans;
Intraocular Pressure;
Membranes*;
Postoperative Complications;
Postoperative Period;
Trabeculectomy
- From:Journal of the Korean Ophthalmological Society
2000;41(7):1569-1576
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
We analyzed the clinical result of trabeculectomy with amniotic membrane transplantation which has antifibrotic and antiinflammatory action in risky glaucoma patients. Subjects were included four eyes of four patients with neovascular glaucoma, one eye of one patient with primary open angle glaucoma and four eyes of three patients with congenital glaucoma. After limbal based scleral flap was made in triangular shape with 5x4 mm sized, amniotic membrane, sized by 6x6 mm with epithelial side up, was placed on the scleral flap and then sutured to medial and lateral portion at 3 mm superior to base of scleral flap base with 10-0 nylon(2 points). The state of bleb, intraocular pressure and complications were observed at postoperative 1st, 3rd, 6th and 9th week. The IOP was reduced from 33.6+/-11.1 mmHg, to 15.5+/-6.5 mmHg at postoperative one week, 17.0+/-8.3 mmHg at three weeks, 16.9+/-8.1 mmHg at six weeks, 17.1+/-6.4 mmHg at nine weeks. 6 eyes(77.7%)had controlled IOP under 21 mmHg without antiglaucomatous agents at last follow up. Avascular blebs were observed throughout postoperative period in all subjects. Postoperative complications were shallow anterior chamber in one eye at 1st week and low intraocular pressue in one eye at 1st, 3rd week, that resolved at six weeks. Trabeculectomy with amniotic membrane transplantation on the scleral flap appeared to be effective as an augment therapy for filtering surgery in risky glaucoma.
